Directory
>
Joshua Cohen
Joshua Cohen
Engineering Researcher | Amylyx Pharmaceuticals
Massachusetts, Canton, United States
Joshua Cohen
Summary
Joshua Cohen is the Co-CEO and Co-Founder of Amylyx Pharmaceuticals, a biotech firm dedicated to developing innovative therapies for ALS and other neurodegenerative diseases. With a strong background in biomedical engineering, he has a proven track record of inventing groundbreaking solutions in the pharmaceutical industry. Prior to founding Amylyx, Joshua worked as an Engineering Researcher at the National Institute of Standards and Technology, where he honed his technical skills. His leadership in the rapidly evolving biotech sector showcases his commitment to improving patient outcomes through science. Joshua's entrepreneurial spirit and passion for engineering drive his vision for the future of medicine. He is also known for his collaborative approach, bringing together diverse teams to tackle complex challenges in healthcare. His educational foundation from Brown University equips him with the analytical skills necessary to lead in a competitive industry. Outside of work, Joshua is likely to be involved in initiatives that promote innovation and sustainability in biopharmaceuticals.
Joshua Cohen
Work Experience
Advisor at
Clara Health
January 2016 - Present
Joshua Cohen
Education
Brown University, Bachelors, Biomedical Engineering
January 2010 - January 2014
Milton Academy, High School
January 1997 - January 2010
Frequently Asked Questions about Joshua Cohen
What is Joshua Cohen email address?
Joshua Cohen's primary email address is ************@amylyx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Joshua Cohen work for?
Joshua Cohen is a Engineering Researcher at Amylyx Pharmaceuticals.
Where Joshua Cohen graduated from?
Joshua Cohen holds a degree in null from Brown University.
How can I directly contact Joshua Cohen?
To contact Joshua Cohen directly, you can use the email address ************@amylyx.com. Complete contact information is available upon registration with Muraena.
Who is Joshua Cohen?
Joshua Cohen is the Co-CEO and Co-Founder of Amylyx Pharmaceuticals, a biotech firm dedicated to developing innovative therapies for ALS and other neurodegenerative diseases. With a strong background in biomedical engineering, he has a proven track record of inventing groundbreaking solutions in the pharmaceutical industry. Prior to founding Amylyx, Joshua worked as an Engineering Researcher at the National Institute of Standards and Technology, where he honed his technical skills. His leadership in the rapidly evolving biotech sector showcases his commitment to improving patient outcomes through science. Joshua's entrepreneurial spirit and passion for engineering drive his vision for the future of medicine. He is also known for his collaborative approach, bringing together diverse teams to tackle complex challenges in healthcare. His educational foundation from Brown University equips him with the analytical skills necessary to lead in a competitive industry. Outside of work, Joshua is likely to be involved in initiatives that promote innovation and sustainability in biopharmaceuticals.